Alkyl substituted indoloquinoxalines
    1.
    发明授权
    Alkyl substituted indoloquinoxalines 有权
    烷基取代的吲哚并噻嗪

    公开(公告)号:US08084453B2

    公开(公告)日:2011-12-27

    申请号:US12496261

    申请日:2009-07-01

    CPC分类号: C07D487/04

    摘要: Novel substituted indoloquinoxalines of formula (I wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X is CO or CH2, Y is OH, NH2, NH—(CH2)n—R3 wherein R3 represents lower alkyl, OH, NH2, NHR4 or NR5R6 wherein R4, R5 and R6 independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4, with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH, and pharmacologically acceptable salts thereof are described. The compounds are useful as drugs for preventing and/or treating autoimmune diseases.

    摘要翻译: 式(I的新型取代吲哚并喹啉,其中R 1为氢或表示选自卤素,低级烷基/烷氧基,羟基,三氟甲基,三氯甲基,三氟甲氧基,R 2中的7至10位的一个或多个相似或不同的取代基表示相似或不同的 C 1 -C 4烷基取代基,X是CO或CH 2,Y是OH,NH 2,NH-(CH 2)n -R 3,其中R 3表示低级烷基,OH,NH 2,NHR 4或NR 5 R 6,其中R 4,R 5和R 6独立地是低级烷基或 环烷基,n为2〜4的整数,条件是当X为CH 2时,Y为OH或NH-(CH 2)n -OH,并描述其药理学上可接受的盐,该化合物可用作药物 用于预防和/或治疗自身免疫性疾病。

    ALKYL SUBSTITUTED INDOLOQUINOXALINES
    2.
    发明申请
    ALKYL SUBSTITUTED INDOLOQUINOXALINES 有权
    烷基取代的吲哚啉酮

    公开(公告)号:US20100009999A1

    公开(公告)日:2010-01-14

    申请号:US12496261

    申请日:2009-07-01

    IPC分类号: A61K31/4985

    CPC分类号: C07D487/04

    摘要: Novel substituted indoloquinoxalines of formula (I wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X is CO or CH2, Y is OH, NH2, NH—(CH2)n—R3 wherein R3 represents lower alkyl, OH, NH2, NHR4 or NR5R6 wherein R4, R5 and R6 independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4, with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH, and pharmacologically acceptable salts thereof are described. The compounds are useful as drugs for preventing and/or treating autoimmune diseases.

    摘要翻译: 式(I的新型取代吲哚并喹啉,其中R 1为氢或表示选自卤素,低级烷基/烷氧基,羟基,三氟甲基,三氯甲基,三氟甲氧基,R 2中的7至10位的一个或多个相似或不同的取代基表示相似或不同的 C 1 -C 4烷基取代基,X是CO或CH 2,Y是OH,NH 2,NH-(CH 2)n -R 3,其中R 3表示低级烷基,OH,NH 2,NHR 4或NR 5 R 6,其中R 4,R 5和R 6独立地是低级烷基或 环烷基,n为2〜4的整数,条件是当X为CH 2时,Y为OH或NH-(CH 2)n -OH,并描述其药理学上可接受的盐,该化合物可用作药物 用于预防和/或治疗自身免疫性疾病。

    ALKYL SUBSTITUTED INDOLOQUINOXALINES
    3.
    发明申请
    ALKYL SUBSTITUTED INDOLOQUINOXALINES 有权
    烷基取代的吲哚啉酮

    公开(公告)号:US20110086859A9

    公开(公告)日:2011-04-14

    申请号:US12496261

    申请日:2009-07-01

    IPC分类号: A61K31/4985

    CPC分类号: C07D487/04

    摘要: Novel substituted indoloquinoxalines of formula (I wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X is CO or CH2, Y is OH, NH2, NH—(CH2)n—R3 wherein R3 represents lower alkyl, OH, NH2, NHR4 or NR5R6 wherein R4, R5 and R6 independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4, with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH, and pharmacologically acceptable salts thereof are described. The compounds are useful as drugs for preventing and/or treating autoimmune diseases.

    摘要翻译: 式(I的新型取代吲哚并喹啉,其中R 1为氢或表示选自卤素,低级烷基/烷氧基,羟基,三氟甲基,三氯甲基,三氟甲氧基,R 2中的7至10位的一个或多个相似或不同的取代基表示相似或不同的 C 1 -C 4烷基取代基,X是CO或CH 2,Y是OH,NH 2,NH-(CH 2)n -R 3,其中R 3表示低级烷基,OH,NH 2,NHR 4或NR 5 R 6,其中R 4,R 5和R 6独立地是低级烷基或 环烷基,n为2〜4的整数,条件是当X为CH 2时,Y为OH或NH-(CH 2)n -OH,并描述其药理学上可接受的盐,该化合物可用作药物 用于预防和/或治疗自身免疫性疾病。

    Alkyl substituted indoloquinoxalines
    4.
    发明申请
    Alkyl substituted indoloquinoxalines 有权
    烷基取代的吲哚并噻嗪

    公开(公告)号:US20050288296A1

    公开(公告)日:2005-12-29

    申请号:US11143935

    申请日:2005-09-08

    CPC分类号: C07D487/04

    摘要: Novel substituted indoloquinoxalines of formula (I wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X is CO or CH2, Y is OH, NH2, NH—(CH2)n—R3 wherein R3 represents lower alkyl, OH, NH2, NHR4 or NR5R6 wherein R4, R5 and R6 independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4, with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH, and pharmacologically acceptable salts thereof are described. The compounds are useful as drugs for preventing and/or treating autoimmune diseases.

    摘要翻译: 式(I)的新型取代吲哚并喹啉,其中R 1是氢或表示选自卤素,低级烷基/烷氧基,羟基,三氟甲基,三氯甲基的7至10位中的一个或多个相似或不同的取代基 ,三氟甲氧基,R 2表示相似或不同的C 1 -C 4烷基取代基,X为CO或CH 2 >,Y是OH,NH 2,NH-(CH 2 CH 2)n -R 3其中R' SO 3表示低级烷基,OH,NH 2,NHR 4或NR 5 R 6 O / 其中R 4,R 5和R 6独立地是低级烷基或环烷基,n是2至4的整数, 其条件是当X是CH 2时,Y是OH或NH-(CH 2)n -OH)及其药理学上可接受的盐 这些化合物可用作预防和/或治疗自身免疫性疾病的药物。

    Alkyl substituted indoloquinoxalines
    5.
    发明授权
    Alkyl substituted indoloquinoxalines 有权
    烷基取代的吲哚并噻嗪

    公开(公告)号:US07589093B2

    公开(公告)日:2009-09-15

    申请号:US11143935

    申请日:2005-06-03

    CPC分类号: C07D487/04

    摘要: Novel substituted indoloquinoxalines of formula wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X is CO or CH2, Y is OH, NH2, NH—(CH2)n—R3 wherein R3 represents lower alkyl, OH, NH2, NHR4 or NR5R6 wherein R4, R5 and R6 independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4, with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH, and pharmacologically acceptable salts thereof are described. The compounds are useful as drugs for preventing and/or treating autoimmune diseases.

    摘要翻译: 低级烷基/烷氧基,羟基,三氟甲基,三氯甲基,三氟甲氧基,R 2表示相同或不同的C1-4烷基的新颖取代吲哚并喹啉,其中R 1为氢或表示选自卤素,低级烷氧基,羟基,三氟甲基,三氯甲基,三氟甲氧基的7至10位中的一个或多个相似或不同的取代基, C4烷基取代基,X是CO或CH2,Y是OH,NH2,NH-(CH2)n-R3,其中R3代表低级烷基,OH,NH2,NHR4或NR5R6,其中R4,R5和R6独立地是低级烷基或环 - 烷基,n是2至4的整数,条件是当X是CH 2时,Y是OH或NH-(CH 2)n -OH,并且其药理学上可接受的盐被描述。 该化合物可用作预防和/或治疗自身免疫性疾病的药物。

    Compounds and use thereof
    6.
    发明授权
    Compounds and use thereof 有权
    化合物及其用途

    公开(公告)号:US08076341B2

    公开(公告)日:2011-12-13

    申请号:US12161081

    申请日:2007-01-22

    CPC分类号: C07D487/04

    摘要: A compound of formula (I) wherein R1 is selected from H, F, Cl, Br, CF3, C1-C6 alkoxy and OH; R2 is selected from H and C1-C6 alkyl; n is 1-12; m is O or 1; Y is selected from CH2, NR3, (NR3R4)+X, O and S; R3 and R4 are independently selected from H and C1-C4 alkyl; and X″ is selected from phannaceutically acceptable anions. A method of preparing the compound, its use as a pharmaceutical, and a method of treatment.

    摘要翻译: 其中R 1选自H,F,Cl,Br,CF 3,C 1 -C 6烷氧基和OH的式(I)化合物; R2选自H和C1-C6烷基; n为1-12; m为O或1; Y选自CH 2,NR 3,(NR 3 R 4)+ X,O和S; R 3和R 4独立地选自H和C 1 -C 4烷基; 并且X“选自药学上可接受的阴离子。 制备化合物的方法,其作为药物的用途和治疗方法。

    NOVEL COMPOUNDS AND USE THEREOF
    7.
    发明申请
    NOVEL COMPOUNDS AND USE THEREOF 有权
    新型化合物及其用途

    公开(公告)号:US20090318458A1

    公开(公告)日:2009-12-24

    申请号:US12161081

    申请日:2007-01-22

    IPC分类号: A61K31/4985 C07D487/04

    CPC分类号: C07D487/04

    摘要: A semiautomatic vehicle gearbox comprising, for said gearbox, a shift lever (10) directly coupled to the gearbox itself; a shaft of said gearbox; and connection means between said shift lever and said shaft; characterised by comprising a sensor (20) for sensing the operation of said shift lever coupled to said connection means.

    摘要翻译: 一种半自动车辆变速箱,包括用于所述变速箱的直接联接到所述变速箱本身的变速杆(10); 所述齿轮箱的轴; 以及所述变速杆和所述轴之间的连接装置; 其特征在于包括用于感测耦合到所述连接装置的所述变速杆的操作的传感器(20)。